Category Archives: Neurotechnology

KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker (NYSE:SYK) today announced the launch of its Pulse Intelligent Delivery Platform, a full-circle product and fulfillment offering optimized for high volume foot and ankle procedures in the ambulatory surgery center (ASC) setting, which will debut at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting (AOFAS), taking place Sept. 14-17 in Qubec City, Canada. The company will also feature its Prophecy Footprint Surgical Planning, which will be the first surgical planning tool to provide clinical guidance on the whole foot in connection with total ankle arthroplasty.

This is an exciting year for Strykers Foot & Ankle business, as we continue to expand our robust portfolio to meet the needs of our surgeon customers, said Michael Rankin, VP Marketing and Medical Education, Strykers Foot & Ankle business unit. With the launch of the Pulse Intelligent Delivery Platform, we now offer a comprehensive suite of products that provides a robust program for foot and ankle surgery within an ASC setting.

The Pulse Intelligent Delivery Platform provides an integrated product configuration and delivery offering for foot and ankle surgery within the ASC setting of care through:

"As surgical procedures continue to migrate to the ASC setting, both surgeons and administrators are looking for ways to streamline their operational efficiency while increasing the reliability of their surgical equipment, said Bruce Cohen, MD, CEO of OrthoCarolina. Efficiency and reliability are exactly what Strykers Pulse platform provides for forefoot procedures in the ASC."

Other Products Debuting at AOFAS

Also being introduced at AOFAS is Prophecy Footprint, an add-on service to Strykers Prophecy Surgical Planning system that provides an understanding of the ancillary procedures to be considered for patients needing total ankle replacement surgery with concomitant pathology. Prophecy Footprint is currently in limited release in the U.S., with plans for a full launch next year.

We also look forward to introducing Prophecy Footprint at AOFAS, which will change the way surgeons prepare and plan for total ankle cases, said Rankin. In order to have a successful total ankle surgery, you have to consider what is going on with the foot itself. By facilitating a more comprehensive view of the foot around the ankle, Footprint can help surgeons with their most complex patient populations.

Rounding out its offering for foot and ankle procedures, Stryker will showcase the CurveBeam AI HiRise weight-bearing computerized tomography (WBCT) imaging system at AOFAS. Strykers Foot & Ankle business has entered into an exclusive co-promotion and distribution agreement with CurveBeam AI, a leader in WBCT. This exclusive agreement will offer a turnkey surgical solution for our foot and ankle surgeon customers treating complex deformities.

Stryker will offer product demonstrations and a virtual reality experience at AOFAS at booth #103 for more information.

About Stryker

Stryker is one of the worlds leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at http://www.stryker.com.

The information presented is intended to demonstrate the breadth of Strykers product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Strykers products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

Go here to see the original:

Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting - Business Wire

In early August 2022, news outlets around the world reported that a team of more than 100 medical staff performed a complex operation to separate conjoined twins fused at the skull.

Three-year-old twins Arthur and Bernardo Lima were born in rural north Brazil in 2018, fused at the top of their heads, and sharing vital cerebral blood vessels. The surgical team had spent months practicing the separation procedure using virtual reality mock-ups based on CT and MRI scans of the twins.

Then, in what surgeon Noor ul Owase Jeelani called space-age stuff, surgeons at the Instituto Estadual do Crebro Paulo Niemeyer in Rio de Janeiro performed seven surgeries on the twins, over more than 27 hours of operating time, with the assistance of colleagues at Great Ormond Street Hospital in London. The two teams, more than 9,000 km apart, liaised using VR headsets. The operation said to be the most complex of its kind ever performed was successful, and the twins have now begun a six-month rehabilitation at the hospital.

The Great Ormond Street surgeons had performed similar procedures in 2006 and 2011. And in 2019, they operated on two-year-old sisters Safa and Marwa Ullah, having first used VR to create an exact replica of the twins skulls, brains, and cerebrovascular systems.

Conjoined twins are rare, occurring in about 1 in 50,000 births, and craniopagus twins who are fused at the skull and share brain tissue account for 2% to 6% of these with an estimated incidence of 1 in 2.5 million births. It is thought that 50 are born each year; of these, 40% are stillborn, and one-third die within a day of birth. About one-quarter survive and are considered for surgical separation.

Subscribe for counterintuitive, surprising, and impactful stories delivered to your inbox every Thursday

The earliest known description of craniopagus twins appears in Sebastian Mnsters Cosmographiae Universalis. The Latin edition, published in 1559, includes a brief reference to twin girls, born in Bierstadt in September 1495, who were joined at the foreheads. It also contains wood cuts showing the girls standing with their heads turned toward each other. These twins reportedly lived to the age of 10, at which point one of them died and was separated from the other; the second died soon afterward. As well as being the first reported case, this seems to be the first recorded case of a separation, and it is also notable for the longevity of the twins.

Craniopagus twins can be broadly divided into partial and total types, depending on the extent to which their skulls are fused, with total craniopagus twins being considered to share a single cranium. The exact point of attachment is variable but occurs most commonly at the parietal bone at the back of the skull.

Successful separation of craniopagus twins was unheard of until relatively recently. The first recorded case of both twins surviving for more than a few hours after separation was published in the early 1950s, and in this case, one of the twins died a month after the operation without regaining consciousness. Since then, advances in brain imaging and neurosurgical techniques have significantly increased the likelihood of a successful outcome following separation.

Exactly how conjoined twins form is unclear. Aristotle claimed that most of them are due to the embryos growing together, but the early embryologists traditionally explained it as the result of an incomplete splitting event at around two weeks of gestation, when the embryo is still a small clump of identical cells. More recently, it has been suggested that craniopagus twins occur as a result of two separate embryos fusing before four weeks of gestation and before neurulation that is, the folding of the neural plate to form the neural tube is finished.

Conjoined twins raise many ethical challenges and philosophical questions. For example, is it morally acceptable to sacrifice one life to save another? And if separation is performed in the early years of life, it will be done without the patients autonomy and informed consent.

Twenty-two years ago, the birth of Gracie and Rosie Attard presented British high court judges with their most difficult case ever. The twins were joined at the abdomen and shared an aorta. Doctors believed that, if separated, one would die at once, but the other would have a 94% chance of survival; if they were not separated, both were likely to die within six months.

The girls parents would not agree to separation on religious grounds and were happy for Gods will to decide what happens, but also were content to leave the decision to the court. The three judges involved in the case agreed that it would be lawful to separate them. After a 20-hour operation, Gracie survived and Rosie died, as expected.

Conjoined twins also raise fascinating questions about self-identity and consciousness. If conjoined twins share brain tissue, might they also share conscious experience? Canadian twins Krista and Tatiana Hogan, who were born in 2006 and remain joined at the skull, provide some clues.

An electroencephalogram (EEG) performed on the twins when they were two years old showed that light shone in one of the pairs eyes evoked a response in the visual cortex in the other. Brain scanning further showed that their brains are connected by a thin piece of tissue, which neurosurgeon Douglas Cochrane of British Columbia Childrens Hospital calls a thalamic bridge.

The thalamus is a deep brain structure that processes sensory information before relaying it to the cerebral cortex and may play a role in conscious awareness. Cochrane therefore believes that the twins experience shared sensations and feelings. Anecdotal evidence for this comes from observations made by their family. As reported in the New York Times Magazine, The family suspected that even when one girls vision was angled away from the television, she was laughing at the images flashing in front of her sisters eyes. The sensory exchange, they believe, extends to the girls taste buds: Krista likes ketchup, and Tatiana does not, something the family discovered when Tatiana tried to scrape the condiment off her own tongue, even when she was not eating it.

According to the CBC documentary Inseparable, the twins also share motor control. Krista and Tatiana Hogan share the senses of touch and taste and even control one anothers limbs. Tatiana can see out of both of Kristas eyes, while Krista can only see out of one of Tatianas Tatiana controls three arms and a leg, while Krista controls three legs and an arm. They can also switch to self-control of their limbs.

Krista and Tatiana say they know one anothers thoughts because they can talk in their heads, but we will probably never know if this is true. Recent advances in neurotechnology make some aspects of consciousness accessible, but an individuals full subjective experience likely always will remain private. For Krista and Tatianas family, there is no question that each of them is an individual they are two normal little girls who happen to go through life sharing a bubble.

See the original post here:

If separating conjoined twins results in death, which one should die? - Big Think

Having made a film on every continent, tireless searcher Werner Herzog keeps things stateside for Theater of Thought. Even so, he travels far, exploring one of the last great frontiers, the human brain, from a rich multitude of angles. The result is one of his most piercing inquiries yet.

In Silicon Valley and in the laboratories and conference rooms of academia, he speaks with more than two dozen people working at the forefront of neuroscience and neurotechnology, the catch-all term for cutting-edge inventions that link the nervous system to electronic and other devices. Herzog is the clear-eyed student at times amazed and delighted, and, at others, skeptical and alarmed. Amid the cryostats and nanoparticles and fiber optics, the clunky gadgets and impenetrable-to-the-layperson diagrams, he summons a wry and lyrical mix of awe and foreboding.

The Bottom LineA quintessentially Herzogian fusion of hope, horror, humor and heart.

Like his 2020 doc, Fireball, a film that studied meteors through chemistry, geology and mythology, entering the kind of territory Joseph Campbell called the inner reaches of outer space, Theater of Thought navigates the places where science and poetics diverge, entwine and sometimes fuse. (Both films were edited with crisp precision by Marco Capalbo.) Herzogs interviewees are entrepreneurs, mathematicians, surgeons, philosophers. For good measure, he spends quality time in the Catskills with a renowned high-wire artist. Crucially, he includes a clip from a Soviet-era silent film, Earth, that captures a character at the brink of death; another character wants him to report back from the other side. The possibility of afterlife communication is one of the what-ifs Herzog asks the experts to ponder, his questions driving the documentarys progression from interview to interview, synapse to synapse.

As Theater peers beneath the skull its only literal glimpse at the pulsating gray matter is a brief one the movie is as steeped in metaphysics as it is in brain science. Its also a trenchant, deeply felt warning: When computers can extract information directly from the brain or feed commands straight into it, privacy, autonomy and the very sense of self are at stake.

For all the unease over ethical questions, the film opens with a pastoral sense of calm: Side by side on a rock beneath trees in brilliant full leaf, Herzog and neurobiologist Rafael Yuste, the films chief scientific adviser, gaze at a laptop. We cant see whats on the screen or hear what theyre saying, but their unforced camaraderie hints at the spontaneous bursts of tenderness that punctuate the doc as when Herzog interviews Cori Bargmann and Richard Axel, scientists who are married to each other, and catches them off guard with his questions about music, and dinner conversation, and the possibility of communicating with animals. Such moments bring to the fore the unspoken challenge that courses through the film: Could a brain-computer interface conjure such emotion, such unexpected chords of sweet, awkward, lovely feeling?

Herzog draws a beaming smile from Daro Gil, IBMs head of research, when, after a tour of the quantum-computer lab, he asks him about fishing. The oceans another frontier whose depths have only begun to be plumbed becomes a subtheme. After posing the somewhat loaded question How stupid is Siri? to AI expert Tom Gruber, one of the creators of the virtual assistant, Herzog admires videos from Grubers dives, sparking a discussion of collective blindness in schools of fish and human societies alike blindness to trawling nets, blindness to destructive courses of action. Neuroscientist Christof Koch insists that Herzog interview him only after hes had his morning row on Puget Sound, immersed in the bliss of being all motion in the flow without thought.

A different kind of flow, one that leaves no room for fear, defines the mental prowess of Philippe Petit, the high-wire artist who enthralled the world with his 1974 walk between the two towers of the World Trade Center (a story told in the magnificent documentary Man on Wire). Its enthralling too to see him nearly 50 years later, practicing his art in his rural New York backyard. Herzogs visit with Petit follows his conversation with Joseph LeDoux, who has mapped the mechanisms of fear in the brain.

At the heart of all this is the mystery of how a mass of ridged and folded tissue, the cerebral cortex, gives rise to consciousness a mystery that remains unsolved even as the experts find ways to interact with neurons, control the nervous system and counteract disorders with such therapeutic procedures as deep brain stimulation. For people who have suffered a stroke or have Parkinsons, the results can be miraculous. An engineer shares his prototype for a chip implant that might restore sight to those with optic nerve damage.

It goes without comment in the film that research on animals is apparently still part and parcel of many of the innovators and scholars work. Herzog is concerned with how people are the guinea pigs. The new brain technologies can regulate behavior and thought in ways that, bioethicist Sara Goering notes, would gratify advertisers. Talk about direct-to-consumer! And so the field of neurorights is a growing legal focus. In 2021, when Herzog was making Theater of Thought, Chile became the first nation to amend its constitution to protect mental privacy and personal identity from invasive technologies. The doc acknowledges this landmark without explaining the amendment, which is being regarded as a potential model for other countries.

Herzogs stateside travels bring him, inevitably, to the projection booth of an old-school movie theater, the Roxie in San Francisco, where he meets neuroscientist Jack Gallant, who studies the human visual system and decodes mental imagery. Surfacing here and in other conversations is another underlying anxiety about neurotechnology, one thats close to Herzogs heart: Will tech-enabled telepathy and other hot-wired feeds to the nervous system render filmmaking and movie watching as we know them obsolete? Or maybe, Herzog ventures, everything we think is real has been a delusion all along. Are we, he asks hauntingly, as only he can, behind our facades, ghostwritten? Having contemplated what makes us human via spectacular prehistoric evidence, the auteur asks us to consider a science fiction future thats closer than we might want to believe.

Continued here:

Theater of Thought Review: Werner Herzog Crafts a Bracing Exploration of Neurotechnology and Consciousness - Hollywood Reporter

Im sure you know at least one of the companies of the billionaire Elon Musk, his dream began looking to facilitate online transactions, that is

digital payments through PayPal. Subsequently, Tesla, focused on the electrification of the automobile industry. Later, SolarCity with the aim of populating rooftops with solar panels. Not to mention SpaceX and its related interests in establishing a colony on Mars! As you can see, the richest person in the world has very interesting plans for the coming years in multiple sectors.

Now he has in sight the power to support people who have suffered the loss of a specific function and even improve the lifestyle of the population and surely you can imagine how he could do it, since it is about installing microchips in the brain to develop functions or, simply, to recover aspects such as mobility lost by accident.

Neurotechnology is within its investment plans and, of course, it is carrying out various projects related to the cause. The last of them has been the probe that has been made regarding the company Synchron, a firm especially focused on the incorporation of brain chips.

The first three places of best-selling gadgets in Amazon Mexico

Alarming detection of nanoplastics in the air

The first thing that should be mentioned is that this possible contact would be directly linked to the difficulty that is taking place in the development of the Neuralink program. Various technical complications have meant that it has not been possible to establish a coordinated proposal and, of course, that the established deadlines are not being met.

Neuralink accumulates a series of delays, which have begun to deteriorate Elon Musks relationship with his own employees. This new agreement could encourage the improvement of its technology over the coming months. It should be remembered that the company hoped to be able to carry out tests on human beings at the end of 2021, this objective having been missed due to the lack of capacity to carry out the program or, simply, due to the lack of knowledge to carry it out.

The main difference that Synchron has with respect to Neuralink is that, in order to work, it is not necessary to cut part of the skull. This may be a differential factor for Elon Musk to have decided to contact Thomas Oxley, the greatest exponent of the North American company. In a way, we find ourselves before a company that is much more capable of carrying out this type of research program. In fact, it has already carried out tests with up to a total of 4 people in Australia.

It should be noted that, according to Reuters information, Synchron has about 60 employees and has so far raised about $65 million from investors. On the contrary, Neuralink employs about 300 workers, so it has, a priori, more alternatives to be able to carry out a project in depth.

Follow this link:

Elon Musk seeks to expand his empire in the world of neurotechnology - Gearrice

BOSTON, September 07, 2022--(BUSINESS WIRE)--VoxNeuro Inc. ("VoxNeuro" or the "Company"), a commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University ("BU"), a world-class institution and private research university at the forefront of neuroscience and neurotechnology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220907005212/en/

From left: Dr. Andrew Budson, MD, Boston University; Dr. Kyle Ruiter, PhD, VoxNeuro; Dr. Katherine Turk, MD, Boston University (Photo: Business Wire)

In partnership with BU, VoxNeuro has launched two studies that will evaluate its cognitive health assessment platform in an outpatient setting to assess diagnostic accuracy. The studies will focus on patients suffering from mild-Traumatic Brain Injury (mTBI)/Concussion and Alzheimers disease, respectively.

On a combined basis, mTBI/Concussion and Alzheimers disease affect over ten million Americans annually, and the inefficiencies of current behavior-based screening methodologies results in considerable excess cost and time to patients, clinicians and the healthcare system. VoxNeuros cognitive health software is expected to provide additive diagnostic information to improve clinical management beyond traditional testing methods. This represents a significant step forward for brain health as VoxNeuro provides for better identification and management strategies.

The studies will be led by Dr. John Connolly, PhD, VoxNeuros Chief Science Officer and Dr. Kyle Ruiter, PhD, VoxNeuros Vice President of Clinical & Scientific Affairs, alongside co-investigators Dr. Andrew Budson, MD, Professor of Neurology at Boston University School of Medicine and Associate Director of Boston Universitys Alzheimers Disease Research Center, and Dr. Katherine Turk, MD, Assistant Professor of Neurology at Boston University School of Medicine and co-Leader of the Outreach, Recruitment and Engagement Core at the Boston University Alzheimers Disease Research Center.

Story continues

"We are excited to test the hypothesis that by combining EEG brainwaves and cognitive testing clinicians may be able to diagnose correctly who is suffering from Alzheimers disease or a brain injury in a manner that may not require a research laboratory to interpret the data," said Dr. Budson.

Dr. Ruiter echoed this excitement, saying, "we are thrilled to be partnering with Boston University, an institution that continues to be at the head of neuroscience research, discovery and innovation. BUs best-in-class team is a pillar of Bostons globally recognized biotech hub and through our collaboration with them we anticipate rich insights into VoxNeuros unique and proprietary data sets that will help drive the development of our second-generation product. Together, we are going to continue to push the boundaries of brain health through innovation."

VoxNeuro anticipates that this will continue to enhance its market awareness and will improve the ability of clinicians to accurately diagnose, treat, and aid in the management of patients suffering from mTBI/Concussion and Alzheimers disease. The Company also anticipates that this work may support new regulatory filings with the FDA and Health Canada.

About VoxNeuro Give the Brain a Voice

VoxNeuro is pushing the boundaries of brain health and empowering healthcare providers with a breakthrough SaMD technology that uses validated brain biomarkers. The Companys EEG-based reports deliver a comprehensive understanding of how a brain is functioning through the objective measurement of a patients attention and concentration, information processing, and working memory. VoxNeuro complements existing clinical workflow to provide clinicians and patients with a more complete picture of brain health, and to inform clinical decision-making.

Visit voxneuro.com to learn more.

Forward-Looking Statements

Certain statements contained in this press release may constitute forward-looking statements under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "expects" or "it is expected", or variations of such words and phrases or statements that certain actions, events or results "will" occur. These forward-looking statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. Accordingly, the actual events may differ materially from those projected in the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements. The Company does not undertake to update any forward-looking statements, except as may be required by applicable securities laws.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005212/en/

Contacts

MediaDouglas Martin416-388-7734media@voxneuro.com

Investor Relations1-833-869-6387investorrelations@voxneuro.com

See the rest here:

VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimers Disease - Yahoo Finance

DUBLIN, Sept. 6, 2022 /PRNewswire/ -- Tri-anim Health Services, a specialty distributor of respiratory, anesthesia and critical care products and therapies, announced today that it has entered into an exclusive relationship to represent and distribute the BrainScope device in hospital Emergency Departments. This innovative point of caredecision support tool is used to objectively assess mild head injured patients for intracranial hemorrhage and concussion at point of care in 20 minutes or less.

BrainScope is an FDA-cleared, handheld Class II medical device that uses artificial intelligence derived algorithms to identify distinctive profiles of structural brain injury and concussion. The solution consists of the BrainScope handheld decision support tool, as well as the BrainScope single-use disposable electrode headset for use with the device.

Tom Metcalf, President of Tri-anim Health Services, said, "This exclusive agreement supports Tri-anim's mission to be the best partner to those who save and improve patients' lives. We are thrilled to bring the breakthrough BrainScope technology to our Emergency Department customers to help them quickly and effectively assess risk of intracranial bleeding in patients with mild head injuries helping to reduce unneeded CT scans, objectively assess concussions, and improve patient experience and satisfaction."

"This partnership with Tri-anim Health Services brings BrainScope to immediate commercial scale. It is a perfect fit for us as Tri-anim's national sales team is already focused on providing innovative solutions to Emergency Departments," said Susan Hertzberg, CEO of BrainScope. Hertzberg added, "America's Emergency Departments are moving beyond COVID care and the demand for BrainScope is rapidly growing to fill a major assessment gap that exists for the nearly 5 million people that present with mild head injuries each year. Up until now, clinicians have had just one tool, the CT scan. With BrainScope they can more confidently rule out those patients that do not need a CT scan while also objectively assess concussion. We are excited to have the commercial reach that Tri-anim provides."

The BrainScope solution has been highly clinically validated with 10+ years of development, 8 successfully executed research contracts funded by the U.S. Department of Defense, and 33 peer-reviewed publications. When integrated into clinical decision making, experience has demonstrated an average 46% reduction in unnecessary CT utilization, a 40% reduction in patient Emergency Department length of stay, and improved patient experience and satisfaction.

"BrainScope helps answer key clinician and patient questionswhether the patient has suffered a brain bleed or concussion, and whether they are ready to resume normal activities. The technological change that BrainScope brings has immediate benefits to both the patient and the Emergency Department," said Dr. Diku Mandavia, Chief Medical Officer at BrainScope.

Attila Morgan, Eastern Area Vice President of Sales for Tri-anim Health Services added,"BrainScope easily fits into the Emergency Department current workflow for mild head injuries. The device can be operated by non-nursing staff and assessments take less than 20 minutes from start to finish. By avoiding unnecessary CT scans, BrainScope's assessment can help Emergency Departments save significant time and hospital resources."

About Tri-anim Health Services

Tri-anim Health Services provides innovative respiratory, anesthesia and critical care products and therapies to hospitals, health systems and other patient care facilities nationwide. As a leader in healthcare excellence for over 45 years, Tri-anim offers targeted solutions, value-oriented programs, clinical expertise, and in-service training to help provide effective and efficient patient care. For more information, visitwww.tri-anim.com.

About BrainScope

BrainScope is a medical neurotechnology company that is improving brain health by providing objective, diagnostic insights that enable better patient care. BrainScope is leading the way in the rapid and objective assessment of brain-related conditions, starting with mild traumatic brain injury (mTBI), utilizing multiple integrated assessment capabilities, artificial intelligence (AI), and digitization. The Company's technology supports the American College of Emergency Physicians (ACEP) Choosing Wisely campaign to avoid CT scans of the head in Emergency Department patients with minor head injury. BrainScope's innovative neurotechnology platform uses EEG-based, AI-derived algorithms empowering physicians to quickly make accurate head injury assessments, addressing the full spectrum of traumatic brain injuries from structural (brain bleed) to functional (concussion) injuries, providing for the first time a full picture of the injury, and doing so in less time and without radiation. For more information, please visit http://www.brainscope.com.

Media Contact:

Beth Scott, Director of Marketing Communications: 614.760.5000 Beth.Scott@sarnova.com

Cision

View original content:https://www.prnewswire.com/news-releases/tri-anim-health-services-announces-exclusive-relationship-to-distribute-brainscopes-breakthrough-technology-for-mild-head-injury-including-concussion-into-emergency-departments-301618276.html

SOURCE Tri-anim Health Services

See the rest here:

Tri-anim Health Services announces exclusive relationship to distribute BrainScope's breakthrough technology for mild head injury including...

TORONTO--(BUSINESS WIRE)-- Myndlift, a health technology company that offers digital mental health programs using the Muse leading consumer EEG technology platform, recently completed a retrospective study using real-world data that offers preliminary efficacy of remote neurofeedback therapy (NFT) on improved mental health outcomes from 593 participants. Little is currently known regarding the effectiveness of remote NFT systems in supporting disorders such as attention-deficit/hyperactivity disorder (ADHD), anxiety, and depression. With this nascent research and continued validation of Myndlifts combination of traditional neurofeedback, CBT tools, and coaching Myndlift hopes to improve access to mental health tools that can remotely support the general focus and wellbeing of patients with these disorders as a low-cost alternative to clinic-based EEG.

Study participants engaged in remote brain training sessions via Myndlifts mobile app utilizing Muses EEG technology to measure their brain activity and complete pre-and post intervention in-app assessments throughout the course of the study. Improvement was measured from self-reported assessments that included validated symptom questionnaires, a cognitive test of attention and executive functioning (ie, continuous performance task), and resting electroencephalography (EEG) markers. Preliminary findings suggest reduced symptom severity from pre- to post-assessment for general psychological health, ADHD, anxiety, and depression, as well as adjusted resting EEG neural markers for individuals with symptoms of ADHD. The full paper was funded by McGill University and published in JMIR Publications in July 2022.

As the digital health space continues to grow thanks to advances in health technology, Muse will continue supporting developers and SDK partners by prioritizing efforts that allow them to leverage their EEG technology in the development of systems that will support the overall health and wellness of patients. The partnership with Myndlift is an indication of the type of applications and subsequent positive impacts that can result when the right wellness and health partnerships and the best quality resources and technology are connected.

There are ample benefits of accessing clinical-grade technology like EEG for accurate and personalized metrics of brain activity which is why the work Muse is doing to make this technology more widely accessible is so important, said Dr. Walter Greenleaf, Stanford Neuroscientist, Digital Medicine expert, and Interaxon Chief Scientific Officer. By continuing to identify ways to support SDK partners like Myndlift in their development of such applications of these innovative technologies, we all work together to push the health tech space forward and develop more accessible and affordable health and wellness solutions.

Improving Access to Clinical Mental Health Treatment with EEG Technology

Neurofeedback training is currently used to support a range of mental health disorders, though there are several barriers to entry that may prevent patients from receiving quality neurofeedback therapeutics. Typically, EEG (electroencephalography) systems are expensive and are usually only accessible in clinical settings. Traditional neurofeedback training programs can range from $6,000 - $8,000 USD. Muse pioneered making EEG technology widely accessible via their brain-sensing headbands for meditation and sleep, which, as a result, have been used in several clinical studies. As an SDK partner, Myndlift has been able to leverage Interaxons technology to offer a more cost-effective solution to their digital health program. Using Muses EEG technology and brain-sensing hardware, neurofeedback therapy can be offered remotely and at a far more affordable cost at an average of $1,500 USDapproximately an 81% cost decrease from traditional training programs.

"We're very proud of these fantastic results, said Aziz Kaddan, Co-Founder and CEO of Myndlift. This peer-reviewed study is one more step in our roadmap to bring data-driven mental wellbeing solutions to market. What's coming is even more exciting!"

Ongoing Opportunities for HealthTech Developers to Contribute to Advances in Healthcare and Wellness Applications

Muse is continually seeking out opportunities to support developers and SDK partners like Myndlift who are taking strides toward creating true innovation within the health and wellness space. As the digital health space, in particular, continues to transform, developers and potential partners interested in using Muses clinical-grade EEG technology to further reimagine health and wellness applications can access Muses SDK for free online. Continually supporting innovators by offering access to their technology and resources remains a key priority for Muse in 2022 and beyond.

Developers and SDK partners who are interested in collaborating can visit http://www.choosemuse.com/sdk to learn more.

About Interaxon Inc.

Interaxon is a late-stage venture company in the neurotechnology space, with a brain and biosensor platform of hardware and software products, a sophisticated data-cloud infrastructure, popular consumer and licensable B2B products, the largest database of brain data in the world, and an IP fortress with several fundamental granted brain, biosignal, VR and AR patents with early priority dates. Interaxon recently completed a Series C investment round to support converting the company's current up-front cost model to an integrated subscription model, further research partnerships, and validation of an industry-first feature tracking longitudinal changes in the brain. Interaxon is headquartered in Toronto, Canada, and has subsidiaries in the U.S. and Ireland.

About Myndlift

Myndlift is a health technology company offering digital mental health using brain-sensing technology and therapist-guided programs. Utilizing Muses EEG technology, the Myndlift platform and hardware allow users access to guided neurofeedback training and digital mental health resources wherever they are. Myndlift works with hundreds of clinics worldwide, and has thousands of users training via the app, available on the App Store and Google Play.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005266/en/

Read more:

Interaxon Inc. (Muse) Highlights Myndlifts Preliminary Study and the Benefit of Partnerships for Digital Therapeutics Research - BioSpace

The twins Elon Musk fathered with Neuralink executive Shivon Zilis were reportedly conceived via in vitro fertilization and the pair did not have a romantic relationship, according to Reuters.

Zilis, 36, reportedly told her colleagues that she was not involved romantically with Musk, 51. Instead, she conceived the children with him through in vitro fertilization (IVF), according to five sources close to the situation. Reuters could not establish the accuracy of Zilis account.

The top executive has worked as Musks director of operations and special projects at the neurotechnology firm for five years. The outlet also reported that Neuralinks 62-page employee handbook prohibits relationships between supervisors and subordinates to avoid any conflicts of interest.

However, Neuralink allegedly accepted Zilis description of her relationship with Musk as non-romantic and has continued her role at the company. Sources also told Reuters that the two have continued working together since the disclosure of their having children. Most recently, sources said Musk had sent Zilis to arrange a meeting with Thomas Oxley, the CEO of Neuralinks competitor, Synchron.

The Tesla CEO secretly had twins in November of 2021, according to court documents obtained by Insider. The children were born weeks before the billionaire welcomed his second child via surrogate with his on-again, off-again partner, the musician Grimes.

In May, a Texas court approved Musk and Zilis petition to change the twins name to have their fathers last name, and contain part of their mothers last name in their middle name. Court documents also show the pair listed the same home address in Austin, Texas.

Zilis, a Yale-educated artificial intelligence specialist, began working with Musk through OpenAI, an artificial intelligence research nonprofit Musk helped found in 2015. She then joined Musk at Tesla as a project director, and went on to work at Neuralink, another Musk-led neurotechnology firm which designs computer implants to allow peoples brains to control electronic devices.

Elon Musk is a father to nine children with three different women. In 2000, the SpaceX founder married his first wife, Canadian author Justine Wilson. Two years later, they welcomed their first child Nevada Alexander Musk, who died of Sudden Infant Death Syndrome (SIDS) when he was 10 weeks old. They went on to have a set of twins Griffin and Vivian Musk in 2004 and triplets Kai, Saxon, and Damian Musk in 2006.

Grimes, whose real name is Claire Boucher, revealed in a Vanity Fair profile in April that she and Musk welcomed their second child a daughter named Exa Dark Siderl Musk in December 2021 via surrogate. The two are also parents to their two-year-old son, X A-12 Musk.

In September 2021, Musk revealed to Page Six that he and Grimes have semi-separated due to conflicting schedules and locations, altough the singer explained to Vanity Fair that the two have a fluid, inexplicable partnership. Grimes tweeted later on that the two have broken up since welcoming their daughter weeks after he fathered twins with Zilis but hes my best friend and the love of my life.

See more here:

Elon Musk and Neuralink executive Shivon Zilis reportedly conceived twins via IVF - The Independent

The globalbiometric wearable marketis expected to grow from USD 42.9 billion in 2022 to USD 82.9 billion by 2027, at a CAGR of 14.1%. The market has a promising growth potential due to several factors, including increasing the advancements in biometric technology across various sectors and rising demand for authentication and identification solutions as well as security and surveillance solutions in various application areas such as in consumer electronics, the government in APAC and other regions.

One of the major factors restraining the growth of the biometric wearable market is increased hygiene concerns and high risk of transmission of coronavirus posed by touch-based biometric solutions. Since the inception of the biometric system, the market players have been offering contact-based biometric solutions for authentication and security purposes. However, over the past two years, the rising hygiene concerns and the increasing risk of the communal spread of coronavirus posed by touch-based biometric solutions have forced manufacturers to focus more on contactless biometrics technologies. According to many experts, COVID-19 is likely to become an endemic disease. There are no studies substantiating the zero presence of the virus in the near future. To curb the spread of this infectious disease, market players are focusing more on building biometric systems based on touchless technologies such as the face, iris, vein, and voice recognition to sustain their position in the biometric system market.

Request To Download Sample of This Strategic Report: https://www.astuteanalytica.com/request-sample/biometric-wearable-market

The market slightly declined in 2020, mainly due to the impact of COVID-19. The supply chains were disrupted in March and April 2020 due to the lockdown imposed by various governments and labor shortages in these industries due to travel restrictions, which would affect the biometric system market. Though the market was impacted in 2020, it is expected to fully recover by mid-2022.

Contactless: The fastest-growing segment of the biometric system market, by Type

The contactless biometric system segment is expected to grow at the highest CAGR during the forecast period. The surging demand for smartphones with face recognition software to increase security drives the market growth. Furthermore, the integration of digital disruptive technologies including AI and automation has uplifted the demand for contactless solutions in the biometric arena. In addition, the rising concerns of the spread of coronavirus through contact-based biometric solutions have contemplated the end-customers to transition toward contactless technologies and the trend shall continue throughout the forecast period.

Software: The segment of the biometric wearable market to grow at the fastest CAGR, by Offering

The software segment is expected to outgrow at a CAGR of 17.8% during the forecast period. The rising demand for strict security offerings to reduce frauds and malicious attacks has generated tremendous interest in biometrics. Software solutions play a critical role in ensuring the interoperability and compatibility of biometric devices. The adoption of cloud-based services and AI for biometric devices is expected to boost the requirement for associated software to ensure the compatibility of devices and operating systems for different applications. Software in biometric systems complements the function of hardware by storing and recalling spatial data; it also allows live data streaming. The emergence of mobile identification solutions such as arrest records, restraining orders, and warrants has been significant drivers for this segmental growth.

Download Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report-https://www.astuteanalytica.com/request-sample/biometric-wearable-market

North America has the largest market share in the biometric system market

North America dominated the biometric wearable market in 2021 with a revenue share of 37.6%. The US and Canada have a strong economy, which empowers them to significantly invest in public safety activities. The early adoption of smart technologies and rising military investments have further fueled the growth of the biometric wearable market in North America. The continuous increase in the use of web applications and websites by end verticals combined with the rising popularity of telehealth services has led to a precipitous increase in the number of identity thefts. This has increased the demand for biometric solutions in the region and shall be continued during the forecast period.

Research Coverage

The report segments the biometric wearable market and forecasts its size, by value, based on region (North America, Europe, APAC, and ROW), by Authentication type (Single Factor and Multi-Factor), Offering (Hardware and Software), Type( Contact-based, Contactless and Hybrid), Mobility (Fixed and Portable) and vertical (government, military & defense, healthcare, banking & finance, travel & immigration, consumer electronics, automotive, security and others).

The report also provides a comprehensive review of market drivers, restraints, opportunities, and challenges in the biometric system market. The report also covers qualitative aspects in addition to the quantitative aspects of these markets.

The report profiles key players in the global biometric wearable market with their respective market share analyses. Prominent players profiled in this report are Thales Group(Paris), Idemia (France), ASSA ABLOY (Sweden), NEC Corporation (Japan), Fujitsu (Japan), Precise Biometrics (Sweden),secunet Security Networks AG (Germany), Stanley Black & Decker, Inc.(France), Aware Inc (US), Cognitec Systems GmbH (Germany), Daon, Inc. (US), DERMALOG Identification Systems GmbH (Germany), Neurotechnology (Lithuania), Innovatrics (slovakia), Veridos GmbH (Germany), ZETES (Belgium), Jumio (US), Onfido (UK), iProov (UK), Facetec, Inc (US), BIO-key International (US), ID R&D Inc (US), Beijing Megvii Technology Co. Ltd.(China), SenseTime (China) Nuance Communications, Inc (US), David Link Manila Corporation (Philipines), Facebanx (UK), Securiport (US), M2SYS Technology (US), SUPREMA (South Korea), Fulcrum Biometrics, Inc, (US), OneSpan (US), Qualcomm Technologies, Inc. (US), Integrated Biometrics (US), Imageware (US), Leidos (US), Papillon Systems (Russia), and Sonda (Chile).

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies. The break-up of the primaries is as follows:

Key Benefits of Buying the Report

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the biometric wearable market and provides them information on key market drivers, restraints, challenges, and opportunities.

Request Full Report-https://www.astuteanalytica.com/request-sample/biometric-wearable-market

About Astute Analytica:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us:

Phone number:+18884296757

Email:sales@astuteanalytica.com

Visit our website:https://www.astuteanalytica.com/

Read the rest here:

Biometric Wearable Market Research Insights with Trends, Competitive Analysis, Opportunities, Forecast 2022 to 2030 Muleskinner - Muleskinner

The Law Society has published a report titled Neurotechnology, law and the legal profession which paints a picture of a legal sector that could be shaped by neurotechnology in the future. In this blog, we will unpick the Law Societys report and try to make sense of this exciting new technology that the Law Society contends will have a huge impact on the legal profession.

What is neurotechnology?

Neurotechnologies are technologies that interact with the brain by monitoring and recording neural activity, and/or acting to influence it. This involves using methods or devices which interface with the nervous system to monitor or modulate neural activity. Current uses of neurotechnology include treating neurological conditions, such as Parkinsons, with deep brain stimulation and treating stroke and tumour presence in the brain with electrophysiology.

What does the report cover?

The report considers the emerging ripples of impact in society and the potential challenges, opportunities and questions facing the legal profession arising from the use of such technology. The ethical, social, political and economic issues considered in the report paint a clear picture of the benefits of the use of neurotechnology such as the huge potential to alleviate suffering caused by neurological and psychiatric conditions. However, the report also raises concerns such as breaches to mental health privacy and the potential for manipulation due to access to brain data.

Like any new technologies, there are pros and cons. However, due to the nature of neurotechnology, any technological advances in this area are going to be widely reported upon and judged, amid calls by some for further regulation and control.

How does this relate to the legal profession?

The Law Society explains in detail how different elements of the profession will be impacted. We will explore these impacts in three sections:

The report states that it will be necessary to consider whether current regulatory systems are adequate in regulating neurotechnology that monitors and stimulates the brain for non-therapeutic purposes.

The Law Society also lists the wide-ranging impact this technology will have on various commercial practice areas such as employment, consumer protection and criminal law. These issues are complex and will require innovative solutions in the profession. For example, in criminal law, would it be acceptable in sentencing for the criminal justice system to monitor and perhaps intervene in an offenders brain whilst they are serving sentences in the community? Whilst at present this is not a problem that needs to be solved, the Law Societys report is clear that in the coming years neurotechnology is expected to develop at a staggering rate and issues such as these will need to be considered and ultimately regulated.

The report also raises challenges that legal educators might start to face in relation to equity and academic integrity as neurotechnology develops. For example, what kinds of neurotechnological assistance are permissible in relation to assessment tasks? What if some students have access to performance-enhancing neurotechnology and others do not? These are questions with which future academic institutions and law firms may have to grapple.

The legal profession could be greatly impacted by developments in neurotechnology. One prediction is that clients may want to change the methods by which work is billed with the attention-monitoring capacities of neurotechnology, billable hours could be changed to billable attention. A second change might be that legal professionals could try to gain an advantage over competitors by using neurotechnology to improve their workplace performance.

Comment

The Law Societys report portrays neurotechnology as something that will have a transformative impact on the legal landscape in the future. In response to this, legal practitioners must rise to the occasion to attempt to maximise the upside and minimise the disadvantages of the technological developments outlined in the report.

Whether this technology has a significant impact on the legal profession is yet to be seen and it is fair to have some scepticism about whether neurotechnology will have the impacts outlined in the report. There is a lot of noise, such as from Elon Musk who predicted that Neuralink (his neurotechnology company) would have chips in human skulls by 2020. This turned out to be overoptimistic and human trials have not yet started. This area contains much uncertainty; however, one thing for sure is that this is an area of law worth watching.

Read more:

Neurotechnology - the future of the legal profession? - Lexology